Aetna Inc. (NYSE:AET) was downgraded by equities research analysts at Sanford C. Bernstein from an “outperform” rating to a “market perform” rating in a report issued on Monday. They presently have a $132.00 target price on the stock. Sanford C. Bernstein’s price target points to a potential upside of 6.80% from the company’s current price.

Other analysts have also recently issued research reports about the stock. Leerink Swann reaffirmed a “buy” rating and set a $135.00 price target on shares of Aetna in a research report on Thursday, August 4th. Zacks Investment Research cut shares of Aetna from a “buy” rating to a “hold” rating in a research report on Monday, August 8th. FBR & Co reaffirmed a “hold” rating on shares of Aetna in a research report on Wednesday, August 17th. Credit Suisse Group AG reaffirmed a “hold” rating and set a $120.00 price target on shares of Aetna in a research report on Wednesday, August 17th. Finally, Wolfe Research cut shares of Aetna from an “outperform” rating to a “peer perform” rating in a research report on Thursday, July 21st. Six equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $132.14.

Analyst Recommendations for Aetna (NYSE:AET)

Aetna (NYSE:AET) opened at 123.5325 on Monday. The stock has a 50 day moving average price of $112.16 and a 200 day moving average price of $115.60. The company has a market cap of $43.35 billion, a PE ratio of 17.8155 and a beta of 0.54. Aetna has a one year low of $92.42 and a one year high of $124.23.

Aetna (NYSE:AET) last issued its quarterly earnings data on Thursday, October 27th. The company reported $2.07 earnings per share for the quarter, topping the consensus estimate of $2.02 by $0.05. Aetna had a net margin of 3.91% and a return on equity of 16.25%. The company had revenue of $15.78 billion for the quarter, compared to analysts’ expectations of $15.71 billion. During the same quarter in the previous year, the firm posted $1.90 earnings per share. Aetna’s revenue for the quarter was up 5.5% on a year-over-year basis. On average, equities analysts anticipate that Aetna will post $8.02 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 28th. Shareholders of record on Thursday, October 13th were paid a $0.25 dividend. The ex-dividend date of this dividend was Tuesday, October 11th. This represents a $1.00 annualized dividend and a yield of 0.81%. Aetna’s dividend payout ratio (DPR) is 14.49%.

In other Aetna news, Director Jeffrey E. Garten sold 7,100 shares of the stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $116.51, for a total value of $827,221.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Shawn M. Guertin sold 45,328 shares of the stock in a transaction dated Tuesday, August 23rd. The shares were sold at an average price of $120.21, for a total transaction of $5,448,878.88. Following the completion of the sale, the insider now owns 44,883 shares of the company’s stock, valued at approximately $5,395,385.43. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by company insiders.

A number of large investors have recently bought and sold shares of the stock. Parkside Financial Bank & Trust increased its position in Aetna by 9.7% in the second quarter. Parkside Financial Bank & Trust now owns 829 shares of the company’s stock worth $101,000 after buying an additional 73 shares in the last quarter. Hartford Financial Management Inc. increased its position in Aetna by 304.8% in the second quarter. Hartford Financial Management Inc. now owns 850 shares of the company’s stock worth $101,000 after buying an additional 640 shares in the last quarter. Ledyard National Bank increased its position in Aetna by 14.4% in the third quarter. Ledyard National Bank now owns 876 shares of the company’s stock worth $101,000 after buying an additional 110 shares in the last quarter. FTB Advisors Inc. increased its position in Aetna by 0.7% in the third quarter. FTB Advisors Inc. now owns 880 shares of the company’s stock worth $101,000 after buying an additional 6 shares in the last quarter. Finally, Acrospire Investment Management LLC increased its position in Aetna by 37.3% in the second quarter. Acrospire Investment Management LLC now owns 1,105 shares of the company’s stock worth $135,000 after buying an additional 300 shares in the last quarter. Hedge funds and other institutional investors own 90.90% of the company’s stock.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).

5 Day Chart for NYSE:AET

Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.